The iFuse system is intended for the fixation of large bones and large bone fragments of the pelvis for conditions that include SI joint disruptions and degenerative sacroiliitis. The minimally invasive procedure uses titanium implants coated with a porous plasma spray designed to decrease the implant motion.
Read more coverage of SI-BONE:
– SI-BONE’s iFuse Implant System Receives CE Mark
– SI-BONE Closes $11M Financing for Commercial and Clinical Expansion
– SI-BONE Begins Post-Market Clinical Experience of iFuse Implant Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
